# DCVC Opportunity Fund II GP, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1668343. Source: https://holderbook.com/funds/1668343-dcvc-opportunity-fund-ii-gp-llc/

- Reported value: $17.2M
- Positions: 2
- Weight of the ten largest: 100.0%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS IN | [RXRX](https://holderbook.com/stocks/RXRX/) | $14.5M | 3,951,141 | 84.3% | 15 |
| IONQ INC | [IONQ](https://holderbook.com/stocks/IONQ/) | $2.7M | 50,705 | 15.7% | 3 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $17.2M | 2 |
| Q1 2026 | $13.9M | 2 |
| Q4 2025 | $16.6M | 2 |
| Q3 2025 | $19.3M | 1 |
| Q2 2025 | $115.3M | 2 |
| Q1 2025 | $81.5M | 2 |
| Q4 2024 | $113.0M | 2 |
| Q3 2024 | $97.4M | 3 |
| Q2 2024 | $65.9M | 3 |
| Q1 2024 | $71.4M | 3 |
| Q4 2023 | $80.9M | 4 |
| Q3 2022 | $77.3M | 5 |